Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.5831
-0.0089 (-1.50%)
At close: Oct 31, 2025, 4:00 PM EDT
0.5700
-0.0220 (-3.72%)
After-hours: Oct 31, 2025, 7:37 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $50.37 million as of October 31, 2025. Its market cap has decreased by -62.13% in one year.
Market Cap
50.37M
Enterprise Value
-53.99M
1-Year Change
-62.13%
Ranking
Category
Stock Price
$0.58
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $50.37M, a decrease of -95.21%. That is a compound annual growth rate of -50.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 50.37M | -41.34% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | 1.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |